FDA Inspection 1273002 — Mark Fesler, M.D.

Mark Fesler, M.D. — FEI 3037144564

The FDA completed an inspection of Mark Fesler, M.D. on May 23, 2025 in Chesterfield, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 23, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chesterfield, MO (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
2272821 CFR 312.64(b)Safety Reports - Non-Serious Events
756021 CFR 312.60FD-1572, protocol compliance